drugset / Trial / NCT03283267
A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a single center, inpatient, open label pharmacodynamic study to determine the effect of 5 g and 10 g doses of Sodium Zirconium Cyclosilicate (ZS) administered once daily (qd) for 4 days on potassium and sodium excretion in healthy Chinese subjects on a standardized, low sodium and high potassium diet.
Timeline
- Start
- 2017-10-24
- Primary completion
- 2017-11-23
- Completion
- 2017-11-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Zirconium Cyclosilicate | Other / unclassified | 5 g | Oral |
| Subject | Sodium Zirconium Cyclosilicate | Other / unclassified | 10 g | Oral |
Indications
No indication recorded.